XML 93 R75.htm IDEA: XBRL DOCUMENT v3.26.1
Notes Payable - 2025 March Unsecured SPA Notes Narrative (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
May 28, 2025
$ / shares
Mar. 21, 2025
USD ($)
day
closing
$ / shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
Dec. 30, 2025
$ / shares
Aug. 14, 2025
$ / shares
May 15, 2025
$ / shares
Dec. 21, 2024
$ / shares
Jul. 31, 2024
$ / shares
Dec. 31, 2023
USD ($)
Debt Instrument [Line Items]                    
Exercise price (in dollars per share) | $ / shares               $ 1.16 $ 110,400  
Class A Common Stock                    
Debt Instrument [Line Items]                    
Share price (in dollars per share) | $ / shares     $ 1.02     $ 3.00        
2025 March Unsecured SPA Notes                    
Debt Instrument [Line Items]                    
Debt instrument, term (in years)     5 years              
Percent of purchaser's conversion shares     100.00%              
Notes Payable                    
Debt Instrument [Line Items]                    
Notes and loans payable     $ 60,666 $ 49,488           $ 91,150
Gain (loss) on extinguishment of debt       (2,699)            
Gain (loss) on fair value adjustment of debts     $ 39,082 34,218            
2025 March Unsecured SPA Notes                    
Debt Instrument [Line Items]                    
Aggregate principal amount   $ 41,000                
Debt instrument, number of closings | closing   4                
Debt instrument, term (in years)   5 years                
Contractual Interest Rates   10.00%                
Debt instrument, redemption price, percentage   10.00%                
Redemption price, percentage   25.00%                
Conversion price (in dollars per share) | $ / shares $ 1.22 $ 1.29 $ 1.22   $ 1.16          
Debt instrument, floor price (in dollars per share) | $ / shares   $ 1.048                
Debt instrument, SPA waiver, term             45 days      
Debt instrument, SPA waiver, deferral period             20 days      
Share price (in dollars per share) | $ / shares             $ 1.00      
Debt instrument, convertible, threshold percentage of stock price trigger 100.00%                  
Debt instrument, exercisable, threshold percentage of stock price trigger 120.00%                  
Exercise price (in dollars per share) | $ / shares $ 1.464   $ 1.464   $ 1.392          
2025 March Unsecured SPA Notes | Series B Preferred Stock                    
Debt Instrument [Line Items]                    
Pro rata aggregate cap (in shares) | shares     9,000,000              
2025 March Unsecured SPA Notes | Notes Payable                    
Debt Instrument [Line Items]                    
Debt instrument, term (in years)     5 years              
Contractual Interest Rates   18.00% 10.00%              
Redemption price, percentage   8.00%                
Debt instrument, convertible, threshold consecutive trading days (in days) | day   5                
Notes and loans payable     $ 2,108 $ 0            
Proceeds from debt, net of issuance costs     34,800              
Debt conversion, converted amount     $ 29,300              
Shares issued from conversion (in shares) | shares     28,551,267              
Gain (loss) on fair value adjustment of debts     $ 2,936              
2025 March Unsecured SPA Notes | Notes Payable | Class A Common Stock                    
Debt Instrument [Line Items]                    
Gain (loss) on extinguishment of debt     $ (26,700)